A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL
Clinical trial NCT06022224 · TERMINATED
Trial details
- NCT number
- NCT06022224
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2022-06-23
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.